Danazol: An Antigonadotrophic Agent in the Treatment of Recurrent Pelvic and Intestinal Endometriosis

Publisher Website
Google Scholar
Abstract
Six cases [human] of pelvic endometriosis were treated with danazol 400 mg daily for 6 mo. In 4 of these cases, intestinal endometriosis of varying severity was also present. The initial results were very satisfactory except in 1 case with adenomyosis and continuous spotting. Follow-up after cessation of treatment suggests that in some cases a further period of treatment is necessary.

This publication has 0 references indexed in Scilit: